the journal of Pharmacy Technology the journal of Pharmacy Technology
Abstracts of Back Issues
Home
Home
Back Issues
Author Information
PharmaCE
Acknowledgments
About the journal
Order Form
Customer Service
Advertising Information
Contact Information


GLYBURIDE/GLIPIZIDE COMBINATION THERAPY IN TYPE 2 DIABETES
Linda A Jaber

To request full article click here.

OBJECTIVE: Research has determined differences in the pharmacokinetics and therapeutic actions ofe glyburid and glipizide. The goal of this study was to evaluate the hypoglycemic effects of glyburide/glipizide combination therapy in the management of patients with diabetes not adequately controlled on either agent alone.

METHODS: Nine patients (3 men, mean age 50.6 ± 11 y) who were hyperglycemic on either glyburide or glipizide monotherapy continued their previous regimen with doses titrated up to maximum daily doses and dietary therapy for 4 weeks, and then they were placed on morning glipizide/evening glyburide combination therapy for 12 weeks.

RESULTS: Combination therapy had no significant effect on glycemic control; no differences in glycosylated hemoglobin (HbAIC) were observed (baseline, 15.3% ± 3.6%; monotherapy, 14.8% ± 3.3%; combination, 13.4% ± 3.5%). However, during combined glyburide/glipizide therapy, fasting plasma glucose was significantly reduced by 53.4 ± 20.0 mg/dL in young (age <50 y) and increased by 73.7 ± 26.9 mg/dL in older subjects. HbAIC was reduced by 3.8% ± 4.0% in young and increased by 1.7% ± 1.3% in older subjects. No significant changes in blood pressure, body weight, or lipid parameters occurred.

CONCLUSIONS: Our preliminary data indicate the limited usefulness of combined glyburide/glipizide therapy. The modest reduction in hyperglycemia observed in patients younger than 50 years of age warrant future studying.

J Pharm Technol 2002;18:9-12.

To request full article click here.


Harvey Whitney Books


Harvey Whitney Books

 
 

the journal of Pharmacy Technology
is published by HARVEY WHITNEY BOOKS COMPANY
8044 Montgomery Road, Suite 415, Cincinnati, OH 45236-2919
P.O. Box 42696, Cincinnati, OH 45242-0696 USA
Tel. 513/793-3555, FAX 513/793-3600
Office Hours: 9-5 E.S.T.
Contact Information
All Rights Reserved. Copyright © 1998-